Nitric Oxide: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Nitric Oxide. Educational only — not medical advice.
Labeled uses
ULSPIRA™ is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents.
Source: FDA labeling via NIH DailyMed (set 026e4541…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.